Merck Animal Division's Dog Flu Treatment Gets Agriculture Department Approval
By Denny Jacob
Merck's animal division said the Agriculture Department has approved its dog flu treatment.
Merck Animal Health's Nobivac NXT Canine Flu H3N2 is expected to be available at veterinary clinics and hospitals nationwide late this summer.
The drugmaker said the product is indicated for the vaccination of healthy dogs eight weeks of age or older against canine influenza H3N2.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
June 25, 2024 16:36 ET (20:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks